V021-4923 Screening compound: N-(2-{4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-3-methoxy-N-(1-phenylethyl)benzamide

V021-4923 Screening compound: N-(2-{4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-3-methoxy-N-(1-phenylethyl)benzamide
V021-4923 Screening compound: N-(2-{4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-3-methoxy-N-(1-phenylethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V021-4923
N-(2-{4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-3-methoxy-N-(1-phenylethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V021-4923

Molecular Formula

C35H39N5O5 (C35 H39 N5 O5)

Compound Name

N-(2-{4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-3-methoxy-N-(1-phenylethyl)benzamide

IUPAC name

N-(2-{4-[6-(24-dimethoxyphenyl)pyridazin-3-yl]-14-diazepan-1-yl}-2-oxoethyl)-3-methoxy-N-(1-phenylethyl)benzamide

SMILES

CC(c1ccccc1)N(CC(N(CCC1)CCN1c(cc1)nnc1-c(ccc(OC)c1)c1OC)=O)C(c1cc(OC)ccc1)=O

InChI

InChI=1S/C35H39N5O5/c1-25(26-10-6-5-7-11-26)40(35(42)27-12-8-13-28(22-27)43-2)24-34(41)39-19-9-18-38(20-21-39)33-17-16-31(36-37-33)30-15-14-29(44-3)23-32(30)45-4/h5-8,10-17,22-23,25H,9,18-21,24H2,1-4H3/t25-/m0/s1

InChI Key

UXYBVNHUUBOTDJ-VWLOTQADSA-N

MDL Number (MFCD)

MFCD19838547

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

609.73

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.914

Distribution Coefficient, logD

4.909

Water Solubility, LogSw

-4.69

Polar Surface Area

79.179

Acid Dissociation Constant (pKa)

22.70

Base Dissociation Constant (pKb)

5.43

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

31.43

V021-4923 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with V021-4923 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V021-4923?
Check Price and Availability of V021-4923, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V021-4923 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V021-4923
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V021-4923
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V021-4923 available by request